NCT01905813 2025-12-19Study of INCB040093 in Subjects With Previously Treated B-Cell MalignanciesIncyte CorporationPhase 1 Active not recruiting121 enrolled
NCT04509700 2025-12-10Rollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465)Incyte CorporationPhase 2 Active not recruiting112 enrolled